These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
173 related articles for article (PubMed ID: 19969097)
21. Amphetamine-induced increases in extracellular dopamine, drug wanting, and novelty seeking: a PET/[11C]raclopride study in healthy men. Leyton M; Boileau I; Benkelfat C; Diksic M; Baker G; Dagher A Neuropsychopharmacology; 2002 Dec; 27(6):1027-35. PubMed ID: 12464459 [TBL] [Abstract][Full Text] [Related]
22. Sleep deprivation decreases binding of [11C]raclopride to dopamine D2/D3 receptors in the human brain. Volkow ND; Wang GJ; Telang F; Fowler JS; Logan J; Wong C; Ma J; Pradhan K; Tomasi D; Thanos PK; Ferré S; Jayne M J Neurosci; 2008 Aug; 28(34):8454-61. PubMed ID: 18716203 [TBL] [Abstract][Full Text] [Related]
23. Acute effects of bupropion on extracellular dopamine concentrations in rat striatum and nucleus accumbens studied by in vivo microdialysis. Nomikos GG; Damsma G; Wenkstern D; Fibiger HC Neuropsychopharmacology; 1989 Dec; 2(4):273-9. PubMed ID: 2482026 [TBL] [Abstract][Full Text] [Related]
24. Dopamine Synthesis Capacity is Associated with D2/3 Receptor Binding but Not Dopamine Release. Berry AS; Shah VD; Furman DJ; White RL; Baker SL; O'Neil JP; Janabi M; D'Esposito M; Jagust WJ Neuropsychopharmacology; 2018 May; 43(6):1201-1211. PubMed ID: 28816243 [TBL] [Abstract][Full Text] [Related]
25. Can recreational doses of THC produce significant dopamine release in the human striatum? Stokes PR; Mehta MA; Curran HV; Breen G; Grasby PM Neuroimage; 2009 Oct; 48(1):186-90. PubMed ID: 19539765 [TBL] [Abstract][Full Text] [Related]
27. Effects of central cholinergic blockade on striatal dopamine release measured with positron emission tomography in normal human subjects. Dewey SL; Smith GS; Logan J; Brodie JD; Simkowitz P; MacGregor RR; Fowler JS; Volkow ND; Wolf AP Proc Natl Acad Sci U S A; 1993 Dec; 90(24):11816-20. PubMed ID: 8265632 [TBL] [Abstract][Full Text] [Related]
28. Serotonergic modulation of dopamine measured with [11C]raclopride and PET in normal human subjects. Smith GS; Dewey SL; Brodie JD; Logan J; Vitkun SA; Simkowitz P; Schloesser R; Alexoff DA; Hurley A; Cooper T; Volkow ND Am J Psychiatry; 1997 Apr; 154(4):490-6. PubMed ID: 9090335 [TBL] [Abstract][Full Text] [Related]
29. Relationship between blockade of dopamine transporters by oral methylphenidate and the increases in extracellular dopamine: therapeutic implications. Volkow ND; Wang GJ; Fowler JS; Logan J; Franceschi D; Maynard L; Ding YS; Gatley SJ; Gifford A; Zhu W; Swanson JM Synapse; 2002 Mar; 43(3):181-7. PubMed ID: 11793423 [TBL] [Abstract][Full Text] [Related]
30. GBR12909 attenuates amphetamine-induced striatal dopamine release as measured by [(11)C]raclopride continuous infusion PET scans. Villemagne VL; Wong DF; Yokoi F; Stephane M; Rice KC; Matecka D; Clough DJ; Dannals RF; Rothman RB Synapse; 1999 Sep; 33(4):268-73. PubMed ID: 10421707 [TBL] [Abstract][Full Text] [Related]
31. Antipsychotic-associated mental side effects and their relationship to dopamine D2 receptor occupancy in striatal subdivisions: a high-resolution PET study with [11C]raclopride. Kim JH; Son YD; Kim HK; Lee SY; Cho SE; Kim YB; Cho ZH J Clin Psychopharmacol; 2011 Aug; 31(4):507-11. PubMed ID: 21694619 [TBL] [Abstract][Full Text] [Related]
33. The hedonic response to cigarette smoking is proportional to dopamine release in the human striatum as measured by positron emission tomography and [11C]raclopride. Barrett SP; Boileau I; Okker J; Pihl RO; Dagher A Synapse; 2004 Nov; 54(2):65-71. PubMed ID: 15352131 [TBL] [Abstract][Full Text] [Related]
34. A positron emission tomography study examining the dopaminergic activity of armodafinil in adults using [¹¹C]altropane and [¹¹C]raclopride. Spencer TJ; Madras BK; Bonab AA; Dougherty DD; Clarke A; Mirto T; Martin J; Fischman AJ Biol Psychiatry; 2010 Nov; 68(10):964-70. PubMed ID: 21035624 [TBL] [Abstract][Full Text] [Related]
35. Quantitation of carbon-11-labeled raclopride in rat striatum using positron emission tomography. Hume SP; Myers R; Bloomfield PM; Opacka-Juffry J; Cremer JE; Ahier RG; Luthra SK; Brooks DJ; Lammertsma AA Synapse; 1992 Sep; 12(1):47-54. PubMed ID: 1411963 [TBL] [Abstract][Full Text] [Related]
36. Imaging dopamine release with Positron Emission Tomography (PET) and (11)C-raclopride in freely moving animals. Patel VD; Lee DE; Alexoff DL; Dewey SL; Schiffer WK Neuroimage; 2008 Jul; 41(3):1051-66. PubMed ID: 18442926 [TBL] [Abstract][Full Text] [Related]
37. Oxytocin enhances attractiveness of unfamiliar female faces independent of the dopamine reward system. Striepens N; Matusch A; Kendrick KM; Mihov Y; Elmenhorst D; Becker B; Lang M; Coenen HH; Maier W; Hurlemann R; Bauer A Psychoneuroendocrinology; 2014 Jan; 39():74-87. PubMed ID: 24275006 [TBL] [Abstract][Full Text] [Related]
39. In vivo quantification of striatal dopamine D2 receptor occupancy by JNJ-37822681 using [11C]raclopride and positron emission tomography. te Beek ET; de Boer P; Moerland M; Schmidt ME; Hoetjes NJ; Windhorst AD; van Berckel BN; Cohen AF; van Gerven JM; Lammertsma AA J Psychopharmacol; 2012 Aug; 26(8):1128-35. PubMed ID: 22290934 [TBL] [Abstract][Full Text] [Related]
40. The dopamine stabilizer (-)-OSU6162 occupies a subpopulation of striatal dopamine D2/D3 receptors: an [(11)C]raclopride PET study in healthy human subjects. Tolboom N; Berendse HW; Leysen JE; Yaqub M; van Berckel BN; Schuit RC; Ponsen MM; Bakker E; Hoetjes NJ; Windhorst AD; Carlsson ML; Lammertsma AA; Carlsson A Neuropsychopharmacology; 2015 Jan; 40(2):472-9. PubMed ID: 25248987 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]